Entia Financial Statements From 2010 to 2026

ERGO Stock  USD 0.0003  0.00  0.00%   
Entia Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Entia Biosciences' valuation are provided below:
Entia Biosciences does not presently have any fundamental signals for analysis.
Check Entia Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entia Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Entia financial statements analysis is a perfect complement when working with Entia Biosciences Valuation or Volatility modules.
  
This module can also supplement various Entia Biosciences Technical models . Check out the analysis of Entia Biosciences Correlation against competitors.

Pair Trading with Entia Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entia Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entia Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Entia Pink Sheet

  0.61VRTX Vertex PharmaceuticalsPairCorr

Moving against Entia Pink Sheet

  0.65ARGX argenx NV ADRPairCorr
  0.56ALNY Alnylam PharmaceuticalsPairCorr
The ability to find closely correlated positions to Entia Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entia Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entia Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entia Biosciences to buy it.
The correlation of Entia Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entia Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entia Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Entia Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Entia Pink Sheet

Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.